News & Updates
Filter by Specialty:
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
Nearly one in three children with chronic hepatitis B (CHB) who discontinued their antiviral treatment has relapsed, a study has shown.
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
19 Aug 2022
Nomogram predicts hydrocephalus risk in children with bacterial meningitis
A recent study has designed a predictive model that can be used by clinicians to determine the risk of hydrocephalus in children with bacterial meningitis.
Nomogram predicts hydrocephalus risk in children with bacterial meningitis
18 Aug 2022
MTX treatment break improves COVID-19 booster response in patients with IMIDs
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
HIV-positive patients tend to receive less cardiovascular care
People living with HIV (PLWH) are less likely to receive preventive cardiovascular (CV) care than non-HIV-infected patients, suggest the results of a study conducted in the same outpatient clinic.
HIV-positive patients tend to receive less cardiovascular care
17 Aug 2022
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.
Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk
16 Aug 2022
PLWH at a disadvantage in receiving statin therapy for ASCVD risk reduction
People living with HIV (PLWH) are less likely to receive appropriate statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD), a study has found.
PLWH at a disadvantage in receiving statin therapy for ASCVD risk reduction
16 Aug 2022
How effective is ensovibep in hospitalized adults with COVID-19?
Hospitalized patients with COVID-19 who are receiving remdesivir and other standard care show no improvements in clinical outcomes with the addition of ensovibep, according to the results of a study.